T1	GGPs 922 927	IL-13
T3	Disorder 779 793	liver fibrosis
T5	Disorder 360 389	idiopathic pulmonary fibrosis
T6	GGPs 89 91	IL
T9	GGPs 633 637	IL-5
T10	GGPs 627 631	IL-4
T13	GGPs 731 736	IL-13
T14	GGPs 1057 1062	IL-13
T17	GGPs 639 644	IL-10
T22	GGPs 874 879	IL-13
T25	Biological_process 208 225	tissue remodeling
T28	Disorder 1311 1330	portal hypertension
T31	Cellular_process 190 206	mucus production
T36	GGPs 1138 1143	IL-13
T37	Disorder 1358 1367	infection
T39	Disorder 352 358	asthma
T46	Anatomical_entity 601 606	liver
T48	Disorder 515 530	schistosomiasis
T49	GGPs 1470 1475	IL-13
T50	Disorder 318 340	debilitating illnesses
T55	Disorder 1246 1255	infection
T56	GGPs 1282 1287	IL-13
T57	Subject 1145 1152	Animals
T63	GGPs 454 459	IL-13
T64	Disorder 1406 1421	schistosomiasis
T68	Subject 499 511	murine model
T69	GGPs 957 977	type-2 IL-4 receptor
T71	GGPs 650 655	IL-13
T74	Disorder 575 592	chronic infection
T79	Disorder 391 409	ulcerative colitis
T80	GGPs 124 139	type-2 cytokine
T81	GGPs 29 51	IL-13 receptor alpha 2
T89	GGPs 76 87	Interleukin
T90	GGPs 532 537	IL-13
T91	GGPs 19 24	IL-13
E4	Biological_process:T25 
E5	Cellular_process:T31 
N12	Reference T3 UMLS:C0239946	Fibrosis, Liver
N16	Reference T5 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N21	Reference T6 UMLS:C1527200	Recombinant Interleukins
N22	Reference T6 UMLS:C0021764	Interleukins
N94	Reference E4 UMLS:C1820201	tissue remodeling
N103	Reference T28 UMLS:C0020541	Hypertension, Portal
N109	Reference E5 UMLS:C2610947	mucus secretion
N130	Reference T37 UMLS:C3714514	Infection
N136	Reference T39 UMLS:C0004096	Asthma
N162	Reference T46 UMLS:C0023884	Liver
N173	Reference T48 UMLS:C0036323	Schistosomiasis
N180	Reference T50 UMLS:C0221423	Illness (finding)
N196	Reference T55 UMLS:C3714514	Infection
N227	Reference T64 UMLS:C0036323	Schistosomiasis
N259	Reference T74 UMLS:C0151317	Chronic infectious disease
N281	Reference T79 UMLS:C0009324	Ulcerative Colitis
N285	Reference T80 UMLS:C0079189	cytokine
N315	Reference T89 UMLS:C0021764	Interleukins
T4	GGPs 76 87;92 95	Interleukin -13
T95	Positive_regulation 105 112	inducer
E16	Positive_regulation:T95 Cause:T4 Theme:E38
T43	Positive_regulation 140 149	dependent
E17	Positive_regulation:T43 Cause:T80 Theme:E38
E18	Positive_regulation:T51 Cause:T4 Theme:E39
E19	Positive_regulation:T51 Cause:T4 Theme:T53
E20	Positive_regulation:T65 Theme:E4 Cause:T4
E21	Positive_regulation:T66 Theme:E5 Cause:T4
T72	Gene_expression 478 490	overproduced
E22	Gene_expression:T72 Theme:T63 disorder:T39
N2	Reference E22 UMLS:C0017262	Gene Expression
T54	GGPs 1001 1012	IL-4R alpha
T24	GGPs 1017 1031	IL-13R alpha 1
T35	GGPs 1078 1092	IL-13R alpha 2
T40	GGPs 1480 1494	IL-13R alpha 2
T32	GGPs 1166 1180	IL-13R alpha 2
T27	Negation_cue 1181 1185	fail
A3	Organism_sbjct T68 Organism
E3	Gene_expression:T72 disorder:T79 Theme:T63
N4	Reference E3 UMLS:C0017262	Gene Expression
E6	Gene_expression:T72 disorder:T5 Theme:T63
N5	Reference E6 UMLS:C0017262	Gene Expression
R2	Subject_Disorder Arg1:T68 Arg2:T48	
T2	Positive_regulation 563 571	mediator
E7	Positive_regulation:T2 Cause:T90 Theme:E40
T8	Positive_regulation 593 600	induced
E8	Positive_regulation:T8 Cause:T74 Theme:E40
E9	Positive_regulation:T26 Cause:T71 Theme:E43
T33	Positive_regulation 767 775	mediator
E10	Positive_regulation:T33 Cause:T13 Theme:T3 atLoc:T23
E12	Positive_regulation:T70 Cause:T17 Theme:E43
E13	Positive_regulation:T67 Cause:T9 Theme:E43
E24	Positive_regulation:T26 Cause:T10 Theme:E43
T12	Positive_regulation 941 949	mediated
E25	Positive_regulation:T12 Cause:T69 Theme:E45
R3	part_of Arg1:T69 Arg2:T54	
R4	part_of Arg1:T69 Arg2:T24	
T19	Negative_regulation 1114 1121	inhibit
E1	Negative_regulation:T19 Cause:T35 Theme:T36
T41	Molecular_function 1153 1162	deficient
E26	Molecular_function:T41 Theme:T32
T44	Negative_regulation 1189 1201	downmodulate
E27	Negative_regulation:T44 Cue:T27 Cause:E26 Theme:E2
A10	Negated E27
R5	Subject_Disorder Arg1:T57 Arg2:T55	
T47	Biological_process 1202 1221	granuloma formation
E2	Biological_process:T47 
N6	Reference E26 UMLS:C0011155	Deficiency
N7	Reference T91 UMLS:C3658037	interleukin-13, human
N8	Reference T81 UMLS:C3814391	Interleukin-13 Receptor Subunit Alpha-2, human
N9	Reference T4 UMLS:C3658037	interleukin-13, human
N10	Reference T63 UMLS:C3658037	interleukin-13, human
R7	member_of Arg1:T4 Arg2:T80	
N14	Reference T22 UMLS:C3658037	interleukin-13, human
N15	Reference T69 UMLS:C1721037	Receptors, Interleukin-4, Type II
N18	Reference T54 UMLS:C1620077	IL4R protein, human
N20	Reference T10 UMLS:C0021758	Interleukin-4
N23	Reference T9 UMLS:C0021759	Interleukin-5
N25	Reference T17 UMLS:C3179724	IL10 protein, mouse
N13	Reference T90 UMLS:C0214743	Interleukin-13
N11	Reference T71 UMLS:C0214743	Interleukin-13
N26	Reference T13 UMLS:C0214743	Interleukin-13
N3	Reference T1 UMLS:C0214743	Interleukin-13
N19	Reference T24 UMLS:C0527729	Interleukin-13 Receptor alpha1 Subunit
N28	Reference T14 UMLS:C0214743	Interleukin-13
N29	Reference T35 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
N30	Reference T36 UMLS:C0214743	Interleukin-13
N31	Reference T32 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
N32	Reference T56 UMLS:C0214743	Interleukin-13
N33	Reference T49 UMLS:C3658037	interleukin-13, human
N34	Reference T40 UMLS:C3814391	Interleukin-13 Receptor Subunit Alpha-2, human
A12	Patient_sbjct T68 Patient
A13	Organism_sbjct T57 Organism
A14	Patient_sbjct T57 Patient
R8	member_of Arg1:T39 Arg2:T50	
R9	member_of Arg1:T5 Arg2:T50	
R10	member_of Arg1:T79 Arg2:T50	
T23	Anatomical_entity 779 784	liver
N54	Reference T23 UMLS:C0023884	Liver
T29	Binding 1063 1070	binding
E11	Binding:T29 Theme:T14 Theme2:T35
N56	Reference E11 UMLS:C1167622	Binding (Molecular Function)
E34	Positive_regulation:T42 Cause:T56 Theme:T18
E31	Positive_regulation:T42 Cause:T56 Theme:T28
T15	Biological_process 1267 1274	develop
E30	Biological_process:T15 Cause:E27 Theme:T18
E35	Biological_process:T15 Cause:E27 Theme:T28
T34	Biological_process 1343 1350	succumb
E36	Biological_process:T34 Cause:E27 Theme:T37
N58	Reference E36 UMLS:C1113651	developmental disease/disorder
N59	Reference E35 UMLS:C1113651	developmental disease/disorder
N60	Reference E30 UMLS:C1113651	developmental disease/disorder
N61	Reference E2 UMLS:C1817882	Granuloma formation
T7	Biological_process 150 161	pathologies
E38	Biological_process:T7 
N24	Reference E38 UMLS:C0699748	Pathogenesis
T38	Biological_process 176 188	inflammation
E39	Biological_process:T38 
T30	Biological_process 607 616	pathology
E40	Biological_process:T30 Theme:T46
N67	Reference E40 UMLS:C0699748	Pathogenesis
R6	part_of Arg1:T46 Arg2:T68	
E41	Correlation:T73 Theme:T49 Theme2:T40 disorder:T64
T45	Biological_process 694 729	granulomatous inflammatory response
E43	Biological_process:T45 
N69	Reference E43 UMLS:C1155266	inflammatory response
N65	Reference E39 UMLS:C1155266	inflammatory response
T61	Pathway 922 937	IL-13 signaling
E45	Pathway:T61 Participant:T1
N71	Reference E45 UMLS:C3158959	interleukin-13-mediated signaling pathway
R11	Subject_Disorder Arg1:T57 Arg2:T28	
R12	Subject_Disorder Arg1:T57 Arg2:T37	
N46	Reference E16 UMLS:C1879547	Activation action
N53	Reference E8 UMLS:C1879547	Activation action
N49	Reference E1 UMLS:C3463820	Inhibition
N50	Reference E27 UMLS:C3463820	Inhibition
T11	Correlation 0 14	Opposing roles
E23	Correlation:T11 Theme:T91 Theme2:T81
N17	Reference E23 UMLS:C0332281	Associated with
N1	Reference E17 UMLS:C1879547	Activation action
T53	Disorder 232 240	fibrosis
N27	Reference T53 UMLS:C0016059	Fibrosis
T51	Positive_regulation 166 175	regulates
N35	Reference E19 UMLS:C1879547	Activation action
T65	Positive_regulation 166 175	regulates
N36	Reference E20 UMLS:C1879547	Activation action
T66	Positive_regulation 166 175	regulates
N37	Reference E21 UMLS:C1879547	Activation action
N38	Reference E18 UMLS:C1879547	Activation action
N39	Reference E7 UMLS:C1879547	Activation action
N44	Reference E10 UMLS:C1879547	Activation action
T26	Positive_regulation 661 669	regulate
N40	Reference E24 UMLS:C1879547	Activation action
T67	Positive_regulation 661 669	regulate
N41	Reference E13 UMLS:C1879547	Activation action
T70	Positive_regulation 661 669	regulate
N42	Reference E12 UMLS:C1879547	Activation action
N43	Reference E9 UMLS:C1879547	Activation action
N45	Reference E25 UMLS:C1879547	Activation action
T18	Disorder 1298 1306	fibrosis
N51	Reference T18 UMLS:C0016059	Fibrosis
R13	Subject_Disorder Arg1:T57 Arg2:T18	
T42	Positive_regulation 1288 1297	dependent
N55	Reference E31 UMLS:C1879547	Activation action
N62	Reference E34 UMLS:C1879547	Activation action
T73	Correlation 1446 1465	opposing activities
N64	Reference E41 UMLS:C0332281	Associated with
N47	Reference T68 UMLS:C0030705	Patients
N48	Reference T57 UMLS:C0030705	Patients
N52	Reference T27 UMLS:C1518422	Negation
